LGALS9 and neoplasm: In addition, a statistically significant, weak positive correlation was observed in the different RCC subtypes and kidney specimen with the proliferation marker CXCR4 as well as with the two tumor immune checkpoint molecules HLA-G and LGALS9 (Table 2).